Jump to content
RemedySpot.com

New Data on Telaprevir and VX-222 for the Treatment of Hepatitis

Rate this topic


Guest guest

Recommended Posts

Guest guest

New Data on Telaprevir and VX-222 for the Treatment of Hepatitis

From the PharmaLive.com News Archive - Mar. 07, 2011

Vertex Pharmaceuticals said 15 abstracts on the company's medicines in

development for hepatitis C, including its protease inhibitor, telaprevir, and

polymerase inhibitor, VX-222, were accepted for presentation at the 46th Annual

Meeting of the European Association for the Study of the Liver.

Link to comment
Share on other sites

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...